Citius Pharmaceuticals
(NASDAQ:CTXR)
$1.20
At close: Aug 17
$1.23
0.0300[2.50%]
PreMarket: 4:42PM EDT
Day High/Low- - -
52 Week High/Low0.83 - 2.01
Open / Close- / -
Float / Outstanding133.8M / 146.1M
Vol / Avg.- / 1.1M
Mkt Cap175.4M
P/E-
50d Avg. Price0.96
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float133.8M

Citius Pharmaceuticals (NASDAQ:CTXR), Quotes and News Summary

Citius Pharmaceuticals (NASDAQ: CTXR)

Day High/Low- - -
52 Week High/Low0.83 - 2.01
Open / Close- / -
Float / Outstanding133.8M / 146.1M
Vol / Avg.- / 1.1M
Mkt Cap175.4M
P/E-
50d Avg. Price0.96
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float133.8M
Sector: Health Care.Industry: Pharmaceuticals
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.050-0.060 -0.0100
REV0
Q2 2022Est.ActualSurprise
EPS-0.050
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Citius Pharmaceuticals Questions & Answers

Q
How do I buy Citius Pharmaceuticals (CTXR) stock?
A

You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Citius Pharmaceuticals's (CTXR) competitors?
Q
What is the target price for Citius Pharmaceuticals (CTXR) stock?
A

The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by HC Wainwright & Co. on Tuesday, January 18, 2022. The analyst firm set a price target for 6.00 expecting CTXR to rise to within 12 months (a possible 400.00% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Citius Pharmaceuticals (CTXR)?
A

The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.2 last updated August 17, 2022, 8:00 PM UTC.

Q
Does Citius Pharmaceuticals (CTXR) pay a dividend?
A

There are no upcoming dividends for Citius Pharmaceuticals.

Q
When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?
A

Citius Pharmaceuticals’s Q3 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Citius Pharmaceuticals (CTXR) going to split?
A

There is no upcoming split for Citius Pharmaceuticals.

Q
What sector and industry does Citius Pharmaceuticals (CTXR) operate in?
A

Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.